Rodney Worthen sold $9,295 of MVST
Chief Financial Officer at Microvast Holdings, Inc.. 2,671 shares at an average of $3.48, traded Nov 25, 2025, filed Jan 29, 2026.
Score components
- +22RoleCFO
- 0Trade size$9k at market
- 0Share of holdings soldSold 7.8% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -16.1%, 3m -27.7%, 6m -70.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000947871-26-000076, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 10, 2025 | AGrant or award Common Stock10b5-1 | +15,000 | - | - | 34,379 | Jan 29, 2026 |
| Nov 25, 2025 | SOpen-market sale Common Stock10b5-1 | -2,671 | $3.48 | $9,295 | 31,708 | Jan 29, 2026 |
| Jan 9, 2026 | AGrant or award Common Stock10b5-1 | +85,714 | - | - | 117,422 | Jan 29, 2026 |
Related signals
Other insiders at Microvast Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 1Weak | Microvast Holdings, Inc. | Yixin Pan director | $35k 12,596 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.